Lansoprazole vs Pembrolizumab
Lansoprazole vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Lansoprazole and Pembrolizumab.
Mechanism of Action
Lansoprazole: Proton pump inhibitor.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Lansoprazole β 1.5 hours; Pembrolizumab β 26 days.
Chemical Properties
Molecular Formula: Lansoprazole β C16H14F3N3O2S.
Molecular Weight: Lansoprazole β 369.3620 g/mol.
Type: Lansoprazole β Small molecule; Pembrolizumab β Antibody.